Novo Nordisk Foundation grants USD 46m to new genomics research center in Boston

A Danish scientist is set to lead the new genomics research center in the US, which the Novo Nordisk Foundation is establishing in collaboration with the Broad Institute of MIT and Harvard.

Photo: Peter Hove Olesen

The Novo Nordisk Foundation is granting USD 46.1m (DKK 290m) to the new international research center, while ramping up its global activities.

The goal is to expand the Danish life science ecosystem by creating global access to leading scientists, technologies and training programs. This is why the commercial foundation, with a net worth of USD 71.5bn (DKK 450bn), plans to establish several similar centers in the coming years, says CEO at the Novo Nordisk Foundation Mads Krogsgaard Thomsen.

Read the whole article

Get 14 days free access.
No credit card required.

An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP recommends nine new drugs, rejects one

Roche and Biogen are among the companies that have received recommendation for approval from the European Medicines Agency's committee (CHMP) at its September meeting. One Pfizer drug was the sole candidate to be rejected.

CEO at WSA: No clarity on EQT exit plans yet

The time horizon for the venture fund EQT's investment in WS Audiology should be ending soon, but according to Group CEO Eric Bernard, there is no clarity on when the potential changes might occur.

Further reading

Related articles

Trial banner

Latest news

See all jobs